207 related articles for article (PubMed ID: 11263458)
1. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring.
Bonati M; Impicciatore P; Pandolfini C
BMJ; 2001 Mar; 322(7285):556. PubMed ID: 11263458
[No Abstract] [Full Text] [Related]
2. Massive variation in Ritalin prescribing.
Gainsbury S
Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
[No Abstract] [Full Text] [Related]
3. Parents accuse APA of Ritalin conspiracy?
J Psychosoc Nurs Ment Health Serv; 2000 Oct; 38(10):12. PubMed ID: 11056888
[No Abstract] [Full Text] [Related]
4. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
Kalb C
Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
[No Abstract] [Full Text] [Related]
5. ADHD, methylphenidate and driving: does some legislation endanger public health?
Verster JC; Cox DJ
J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
[No Abstract] [Full Text] [Related]
6. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
Shalev R; Gross-Tsur V
Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
[No Abstract] [Full Text] [Related]
7. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
8. Attention-deficit-hyperactivity disorder.
Diller LH
N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
[No Abstract] [Full Text] [Related]
9. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
10. Methylphenidate.
St Dennis C; Synoground G
J Sch Nurs; 1996 Feb; 12(1):5-8, 10-1. PubMed ID: 8696016
[No Abstract] [Full Text] [Related]
11. Nurse-delivered and doctor-delivered care in an attention deficit hyperactivity disorder follow-up clinic: a comparative study using propensity score matching.
Foreman DM; Morton S
J Adv Nurs; 2011 Jun; 67(6):1341-8. PubMed ID: 21375572
[TBL] [Abstract][Full Text] [Related]
12. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
Golubchik P; Weizman A
Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
[No Abstract] [Full Text] [Related]
13. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
Taéron C
Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
[No Abstract] [Full Text] [Related]
14. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
15. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
16. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
Gumy C; Huissoud T; Dubois-Arber F
J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
[TBL] [Abstract][Full Text] [Related]
17. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
Wigal SB; Wilens TE; Wolraich M; Lerner M
Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
[TBL] [Abstract][Full Text] [Related]
18. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
[TBL] [Abstract][Full Text] [Related]
19. [A reply concerning scientologists and ADHD: Scientific evidence and indications for treatment with methylphenidate].
Zetterström R
Lakartidningen; 2002 Mar; 99(14):1618-9. PubMed ID: 12025221
[No Abstract] [Full Text] [Related]
20. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
Gadow KD; Sverd J
Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
